Delivery Order SPE2DB20D2104-SPE2DB22FS22R
Award Date 3/28/22
Potential Completion Date 3/29/22
Potential Value $1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award is for the delivery of Azelastine 0.1% (137 mcg) spray, 30 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $1,415.26. The contract is structured as a Firm Fixed Price Delivery Order, with a period of performance through September 26, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Azelastine 0.1% (137 mcg) Spray, 30 mL, with a firm fixed price of $1,547.25 and an ultimate completion date of September 13, 2024. The contract is not set aside for any small business designation. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order under a larger Indefinite...
- This federal contract award, with ID SPE2DB20D2001|SPE2DB23FM34M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,084.96 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray in 30 mL containers. The contract has an ultimate completion date of January 4, 2023 and was awarded on January 3, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp, as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.62, is for the delivery of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. This order was issued under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., with a ceiling...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,029.59 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) spray, a pharmaceutical product, with a completion date of November 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.00 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, 30ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical...
- This federal contract award, identified as SPE2DB20D2001|SPE2DB22FM44L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.44 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) nasal spray, a medication used for the treatment of nasal symptoms associated with allergies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ05A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,237.04 delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, with a completion date of September 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- The Defense Logistics Agency awarded a $525.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561926547 units of 0.1% azelastine hydrochloride 137 mcg sprays in 30mL bottles to the DLA from its facility in Conshohocken, Pennsylvania under a period of performance spanning August 24 to August 25, 2023. No subcontractors or set aside designations were indicated. The DLA...